德康医疗 2024年度报告

FORM10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year endedDecember31, 2024 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 33-0857544 (I.R.S. Employer Identification No.) (858)200-0200(Registrant’s telephone number, including area code) Securities registered pursuant to Section12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock, $0.001 Par Value Per ShareDXCMNasdaq Global Select Market Securities registered pursuant to Section12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes☒No☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section13 or 15(d) of the Act.Yes☐No☒ Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required tofile such reports), and (2)has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for suchshorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated file Large accelerated filer☒Non-accelerated filer☐ Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transitionperiod for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of theExchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of theeffectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b))by the registered public accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements ofthe registrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevant recovery periodpursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes☐No☒ As of June28, 2024, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregatemarket value of the registrant’s common stock held by non-affiliates of the registrant was approximately $45.3billion based onthe closing sales price of $113.38 per share as reported on the Nasdaq Global Select Market on that date. Shares held bypersons who may be deemed affiliates have been excluded. This determination of affiliate status with respect to the foregoingcalculation is not a determination for other purposes. Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicabledate. Outstanding at February 6, 2025390,772,018 Common stock, $0.001 par value per share DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders (the “ProxyStatement”) are incorporated by reference in PartIII, Items 10 through 14 of this Annual Report on Form 10-K, as specified inthe responses to those item numbers, which proxy statement will be filed with the Securities and Exchange Commission within120 days after the end of the fiscal year covered by this Form 10-K. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Except for historical financial information contained herein, the matters discussed in this Annual Report on Form 10-K may beconsidered forward-looking statements within the meaning of Section27A of the Securities Act of 1933, as amended, or theSecurities Act, and Section21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and subject to thesafe harbor created by the Private Securities Litigation Reform Act of 1995. Such statements include declarations regarding ouroper